- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03435783
Brief Electronic Intervention for Heavy Drinking and Sex Risk Among MSM Seeking HIV Testing
April 18, 2019 updated by: Tyler Wray, Brown University
The overall objective of this research is to use both qualitative and quantitative data to inform the development of a technology-based intervention for heavy drinking and sexual risk behavior among men who have sex with men (MSM) who are seeking free HIV testing.
Investigators will be conducting a randomized-controlled pilot test of the intervention among MSM seeking HIV testing in community-based settings to explore its potential impact on alcohol and HIV-related behavioral outcomes.
This research will ultimately produce a combined, theory-based, and technology- delivered intervention for heavy drinking and sex risk that is fully portable and has been preliminarily tested for efficacy in community settings where high-risk MSM engage with prevention services.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02901
- Brown University School of Public Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Biologically male
- Aged 18 or older
- Fluent English speaker
- Unprotected anal sex with a casual male partner at least once in the past 3 months
- Heavy alcohol use during the past 2-weeks (>14 drinks per week, or at least one occasion of 5+ drinks on a given occasion)
- Breath alcohol concentration (BrAC) of .000 at the time of enrollment
- No history of complex alcohol withdrawal
- HIV-negative
Exclusion Criteria:
- Individuals who are HIV-positive
- Individuals who participated in other phases of the research
- Individuals who report being coerced to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
|
The brief electronic intervention will allow users to receive normative feedback based on their alcohol use and sexual activity.
Users who show interest in changing their behavior will also be asked to create a plan to do so.
|
|
Active Comparator: Attention-matched control
|
Participants will view a video clip on general health promotion that is a similar length as the intervention arm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of New Sex Partners, Past 30 Days
Time Frame: Past 30 days
|
Assessed via self-report using Timeline Follow Back (TLFB)
|
Past 30 days
|
|
Number of Condomless Anal Sex Events, Past 30 Days
Time Frame: Past 30 days
|
Assessed via self-report using Timeline Follow Back (TLFB); count of the number of such events.
|
Past 30 days
|
|
Number of Drinking Days, Past 30 Days
Time Frame: Past 30 days
|
Assessed via self-report using Timeline Follow Back (TLFB); count of the average number of drinking days in the past 30
|
Past 30 days
|
|
Number of Heavy Drinking Days (5 or More), Past 30 Days
Time Frame: Past 30 days
|
Assessed via self-report using Timeline Follow Back (TLFB); count of the number of days.
|
Past 30 days
|
|
Average Number of Drinks Per Drinking Day
Time Frame: Past 30 days
|
Assessed using Timeline Follow Back (TLFB)
|
Past 30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 13, 2017
Primary Completion (Actual)
March 3, 2018
Study Completion (Actual)
March 3, 2018
Study Registration Dates
First Submitted
August 2, 2017
First Submitted That Met QC Criteria
February 15, 2018
First Posted (Actual)
February 19, 2018
Study Record Updates
Last Update Posted (Actual)
April 23, 2019
Last Update Submitted That Met QC Criteria
April 18, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1411001155
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CAN Community HealthGilead Sciences; Midway Specialty Care Center; Costello Medical Inc.Not yet recruitingHIV | HIV 1 Infection | HIV -1 Infection | HIV (Human Immunodeficiency Virus)United States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV Infections | HIV SeronegativityUnited States, Puerto Rico
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
Clinical Trials on Brief Electronic Intervention
-
Florida State UniversityNexo Asociacion CivilTerminated
-
i4HealthTerminated
-
University of Texas at AustinNational Institute on Drug Abuse (NIDA)Completed
-
New York State Psychiatric InstituteCompletedDepression | Mental Health Disorder | Adolescent Behavior | Stigma, SocialUnited States
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)CompletedDrug Abuse | HIV Risk BehaviorUnited States
-
Wayne State UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)CompletedRisk Behavior | Marijuana Use | Alcohol Consumption | Unsafe Sex
-
New York State Psychiatric InstituteCompletedDepression | Mental Health Disorder | Stigma, SocialUnited States
-
University of California, San FranciscoCompletedMetabolic HealthUnited States
-
University of MichiganNational Institute on Drug Abuse (NIDA)CompletedDrug Use | Sex BehaviorUnited States